Drug licences for cash scandal unfolds in Italy

The director of Italy's medicines regulatory agency has been suspended along with another top official, as the drug licences-for-cash scandal surrounding the organisation continues to unfold. Nello Martini, director of Aifa (the Italian Agency for Pharmaceuticals), has been suspended along with Caterina Gualano, head of medicines registration for the agency. The development follows a two-year investigation in which police found evidence that money had changed hands in return for the falsification of clinical data required for drug licences.
Read article at pharmatimes.com